Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Audit finds high levels of hidden ketosis
30 per cent of newly calved cows in state of subclinical ketosis

In a recent audit of UK dairy herds, it was found that the prevalence of subclinical or 'hidden' ketosis averaged 30 per cent in newly calved cows. Levels in individual herds varied from 10 to 60 per cent. These cows were not only found to be more likely to develop clinical ketosis, but were also at greater risk of developing other metabolic and reproductive disorders such as retained placenta, displaced abomasum and milk fever.

763 cows from 15 dairy herds were tested in the UK farm audits. Ketosis was determined by measuring beta-hydroxbutyrate (BHBA) levels in the milk of cows which had calved 7 to 21 days previously. Levels were measured using the cow-side diagnostic Keto-Test, and a positive diagnosis was given when BHBA levels exceeded 100mol/litre. The cows were also observed during the first 35 days of lactation, not only to see if clinical ketosis developed, but also to monitor other potential health problems that may arise.

The study was also conducted across four other European countries - Germany, France, Italy and The Netherlands, testing a total of 2,489 cows. The audit revealed that cows testing positive for hidden ketosis were 11.5 times more likely to progress to clinical ketosis. They were also 1.7 times more likely to have a difficult calving, 2.2 times more likely to have had a retained placenta and 1.8 times more likely to have had milk fever.

Other results suggested these animals were 4.5 times more likely to suffer gastrointestinal distress, 2.3 times more likely to get mastitis and 2.7 times more likely to get a displaced abomasum. The audit additionally found a small but significant trend indicating an increased susceptibility to metritis.

Technical consultant for Elanco Mike Steele said: "Clinical ketosis was diagnosed in 1 per cent of cows surveyed in the main audit. This is in line with previous findings. It highlights that whilst clinical cases of ketosis are rare, these cases are just 'the tip of the iceberg' and a much larger number of animals will be experiencing subclinical levels of ketosis.

"These may develop into clinical ketosis and/or other clinical disease, as the survey demonstrated."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.